4//SEC Filing
Bellerophon Therapeutics, Inc. 4
Accession 0001628280-16-021955
CIK 0001600132operating
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 4:21 PM ET
Size
5.4 KB
Accession
0001628280-16-021955
Insider Transaction Report
Form 4
Tenenbaum Fabian
Chief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2016-12-07+1,042,556→ 1,042,556 totalExercise: $0.49Exp: 2026-12-06→ Common Stock (1,042,556 underlying)
Footnotes (1)
- [F1]The option grant was approved by Bellerophon Therapeutics, Inc.'s board of directors on December 7, 2016, subject to stockholder approval of an amendment to the stock option plan under which the option was granted.
Documents
Issuer
Bellerophon Therapeutics, Inc.
CIK 0001600132
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001600132
Filing Metadata
- Form type
- 4
- Filed
- Dec 8, 7:00 PM ET
- Accepted
- Dec 9, 4:21 PM ET
- Size
- 5.4 KB